CDP Venture Capital

Iama Therapeutics specializes in neuroscience drug discovery, aiming to develop innovative medicines for children with brain disorders. Their mission is to improve the lives of these children and provide support to their families.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

Salute360 is an online platform offering healthcare information and related services. It enables users to book consultations with healthcare professionals, order medicines for home delivery within hours, and connect with local pharmacists.

Genoa Instruments develops advanced super-resolution optical microscopes for biomedical research. Its innovative platform integrates spatial and temporal resolution, enabling high-detail imaging of living samples. The company aims to democratize access to high-resolution imaging, driving scientific discovery and healthcare research.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Founded in 2018, Restorative Neurotechnologies designs and develops non-invasive neuromodulation devices for cognitive rehabilitation. The company aims to provide innovative solutions for rehabilitation and cognitive enhancement.

Genespire is a biotechnology company dedicated to developing innovative gene therapies for patients suffering from genetic diseases, with a particular emphasis on primary immunodeficiencies and inherited metabolic disorders. The company specializes in creating therapies that utilize integration-defective lentiviral vectors combined with gene editing techniques. This approach allows for highly effective and adaptable targeted insertion of therapeutic genes into blood cells, providing patients with a range of tailored therapeutic options suited to their specific conditions. By focusing on transformative solutions, Genespire aims to significantly improve the lives of individuals affected by severe genetic disorders.

Aptadir Therapeutics is a biotechnology company focused on developing novel treatments for diseases associated with abnormal DNA methylation. The company's approach involves using RNA therapeutics to inhibit the function of DNMT1, an enzyme responsible for adding methyl groups to DNA. Specifically, Aptadir is working on a treatment for Myelodysplastic Neoplasms, a group of conditions that affect the blood and bone marrow.

Salute360 is an online platform offering healthcare information and related services. It enables users to book consultations with healthcare professionals, order medicines for home delivery within hours, and connect with local pharmacists.

Diadem develops a blood-based diagnostic test utilizing a proprietary antibody targeting a specific conformation of the p53 protein. Its platform aims to predict and monitor Alzheimer's disease progression, enabling early diagnosis and cost-effective treatment.

Founded in 2018, Restorative Neurotechnologies designs and develops non-invasive neuromodulation devices for cognitive rehabilitation. The company aims to provide innovative solutions for rehabilitation and cognitive enhancement.